Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna M Corcoran

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Neuro-Oncology|January 29, 2026
Leveraging Single-Cell Profiling in Early-Phase Trials to Guide Rational Therapy DevelopmentJulia Louw, Jodie Jepson, Anna M Corcoran, et al.
Trends in Cancer|November 14, 2025
The promise of TIL therapy for glioblastomaEmma L Pristo, Kelly M Hotchkiss, Anna M Corcoran, et al.
Biorxiv : the Preprint Server for Biology|April 16, 2025
A Spatial Multi-Omic Framework Identifies Gliomas Permissive to TIL ExpansionKelly M Hotchkiss, Kenan Zhang, Anna M Corcoran, et al.
Scientific Reports|October 23, 2025
A surgical window of opportunity trial evaluating the effect of the PCSK9 inhibitor evolocumab on tumoral MHC-I expression and CD8<sup>+</sup> infiltration in gliomaKirit Singh, Matthew W Foster, Marlene J Violette, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Neuro-Oncology|January 29, 2026
Leveraging Single-Cell Profiling in Early-Phase Trials to Guide Rational Therapy DevelopmentJulia Louw, Jodie Jepson, Anna M Corcoran, et al.
Trends in Cancer|November 14, 2025
The promise of TIL therapy for glioblastomaEmma L Pristo, Kelly M Hotchkiss, Anna M Corcoran, et al.
Biorxiv : the Preprint Server for Biology|April 16, 2025
A Spatial Multi-Omic Framework Identifies Gliomas Permissive to TIL ExpansionKelly M Hotchkiss, Kenan Zhang, Anna M Corcoran, et al.
Scientific Reports|October 23, 2025
A surgical window of opportunity trial evaluating the effect of the PCSK9 inhibitor evolocumab on tumoral MHC-I expression and CD8<sup>+</sup> infiltration in gliomaKirit Singh, Matthew W Foster, Marlene J Violette, et al.
Pageof 1